IL2 and cancer: The differential readout of NK cell viability was further employed to demonstrate that the administration of cytokines (e.g., IL-2, IL-15, and IL-21) improved the in vivo survival of NK cells and led to better anti-cancer outcomes in a mouse model of hepatocellular carcinoma.